Circulating microRNA-636 is associated with the elimination of hepatitis C virus by ombitasvir/paritaprevir/ritonavir

Hepatitis C virus (HCV) infection causes sustained inflammation and fibrosis. Several oral direct-acting antivirals (DAAs) including ombitasvir/paritaprevir/ritonavir (OBV/PTV/r) were recently developed for HCV elimination. The combination of DAAs brought a higher sustained viral response (SVR) rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Morishita, Asahiro, Yoneyama, Hirohito, Iwama, Hisakazu, Fujita, Koji, Watanabe, Miwako, Hirose, Kayo, Tadokoro, Tomoko, Oura, Kyoko, Sakamoto, Teppei, Mimura, Shima, Nomura, Takako, Oryu, Makoto, Himoto, Takashi, Shimotohno, Kunitada, Masaki, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112829/
https://www.ncbi.nlm.nih.gov/pubmed/30174796
http://dx.doi.org/10.18632/oncotarget.25889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112829/
https://www.ncbi.nlm.nih.gov/pubmed/30174796
http://dx.doi.org/10.18632/oncotarget.25889

Ejemplares similares